Therapeutic Area Partnerships is a uniquely efficient gathering bringing together decision-makers to assess the most promising drug programs available for partnering in Cardiovascular/Metabolic Diseases, Neuroscience, Anti-Inflammatory/Autoimmune Diseases, Oncology/Immuno Oncology, Infectious and Emerging Diseases, Advanced Therapies (Cell, Gene and Stem Therapies), Orphan and Rare Diseases, and Academic Technology Transfer. Respected independent experts rigorously review projects available for partnering and select the top 8 projects in each therapeutic area based on the likelihood of their success as future products. Many presenting companies have gone on to headline-making partnerships.
Attendees have the opportunity to hear from and meet some of the industry's most talented biotechnology entrepreneurs and pharmaceutical leaders. Casual gatherings and one-on-one partnering meetings bring together business development decision makers from large pharmaceutical firms and executive leadership from innovative biotechnology firms to make this one of the industry's most productive events. Attendees benefit from two days of:
-Actionable expert analysis of trends and opportunities in licensing and MandA deal making
-Business insights from the industry's foremost thought leaders and decision makers
-Information on emerging biomedical opportunities, innovative companies and key licensable projects
-Strategies for leading, financing and partnering biopharmaceutical programs
-Insights into fast-changing therapeutic areas and the companies at their forefront
-Productive and intimate networking and conversations with top-level peers from around the world
Attendees have the opportunity to hear from and meet some of the industry's most talented biotechnology entrepreneurs and pharmaceutical leaders. Casual gatherings and one-on-one partnering meetings bring together business development decision makers from large pharmaceutical firms and executive leadership from innovative biotechnology firms to make this one of the industry's most productive events. Attendees benefit from two days of:
-Actionable expert analysis of trends and opportunities in licensing and MandA deal making
-Business insights from the industry's foremost thought leaders and decision makers
-Information on emerging biomedical opportunities, innovative companies and key licensable projects
-Strategies for leading, financing and partnering biopharmaceutical programs
-Insights into fast-changing therapeutic areas and the companies at their forefront
-Productive and intimate networking and conversations with top-level peers from around the world
